Skip to main content
logo
Balchem Corporation (BCPC)
NASDAQ: BCPC · Real-Time Price · USD
169.28
+3.24 (1.95%)
Jun 24, 2026, 4:00 PM EDT - Market closed

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Revenue
672.56M659.39M600.26M
Human Nutrition and Health Revenue Growth
2.00%9.85%8.99%
Animal Nutrition and Health Revenue
235.76M230.85M214.71M
Animal Nutrition and Health Revenue Growth
2.13%7.52%-9.91%
Specialty Products Revenue
142.43M140.98M132.75M
Specialty Products Revenue Growth
1.03%6.20%5.39%
Other and Unallocated Business Segment Revenue
6.60M5.95M5.97M
Other and Unallocated Business Segment Revenue Growth
11.02%-0.35%-19.33%
Revenue (Other)
-1.00K-1.00K-
Revenue (Total)
1.06B1.04B953.68M
Revenue (Total) Growth
1.95%8.75%3.39%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
771.11M759.45M723.30M
United States Revenue Growth
1.54%5.00%4.89%
Foreign Countries Revenue
286.24M277.71M230.38M
Foreign Countries Revenue Growth
3.07%20.54%-1.05%
Revenue (Other)
-1.00K-1.00K-
Revenue (Total)
1.06B1.04B953.68M
Revenue (Total) Growth
1.95%8.75%3.39%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Product Sales Revenue
1.06B1.04B951.95M
Product Sales Revenue Growth
1.95%8.75%3.48%
Royalty Revenue
1.92M1.89M1.74M
Royalty Revenue Growth
1.85%8.75%-30.19%
Revenue (Total)
1.06B1.04B953.68M
Revenue (Total) Growth
1.95%8.75%3.39%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Earnings From Operations
155.95M153.91M135.96M
Human Nutrition and Health Earnings From Operations Growth
1.33%13.20%32.75%
Animal Nutrition and Health Earnings From Operations
19.14M18.69M14.01M
Animal Nutrition and Health Earnings From Operations Growth
2.44%33.36%-49.18%
Specialty Products Earnings From Operations
45.25M42.90M39.91M
Specialty Products Earnings From Operations Growth
5.48%7.51%15.40%
Other and Unallocated Business Segment Earnings From Operations
-6.41M-6.17M-6.97M
Operating Income (Total)
213.94M209.33M182.91M
Operating Income (Total) Growth
2.20%14.44%14.90%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Backlog
39.59B39.96B
Human Nutrition and Health Backlog Growth
-0.93%23.26%
Animal Nutrition and Health Backlog
11.49B9.04B
Animal Nutrition and Health Backlog Growth
27.16%18.27%
Specialty Products Backlog
1.93B1.28B
Specialty Products Backlog Growth
50.54%-52.05%
Other Business Segment Backlog
356.00M137.00M
Other Business Segment Backlog Growth
159.85%-38.29%
Total Backlog
53.37B50.42B
Total Backlog Growth
5.85%17.36%